Luis
Montuenga Badía
Catedrático de Universidad
Hospital Vall d'Hebron
Barcelona, EspañaPublications in collaboration with researchers from Hospital Vall d'Hebron (9)
2023
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
2022
-
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity
The Journal of experimental medicine, Vol. 219, Núm. 12
2021
-
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Molecular Oncology, Vol. 15, Núm. 4, pp. 887-900
2020
-
Epigenetic SmAd3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma
Cancer Research, Vol. 80, Núm. 2, pp. 276-290
-
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282
2019
-
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Thorax, Vol. 74, Núm. 4, pp. 371-379
-
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899
2017
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97